A pharmaceutical company targeting unmet clinical needs.

Herantis Pharma was created by a merger of two pharmaceutical companies, Hermo Pharma and Laurantis Pharma.

Pipeline

Overview

Herantis has a product development portfolio focused in areas of unmet clinical need, based on internationally recognized science.

Read More

Herantis Pharma Oyj: Manager's Transactions - Pekka Simula

Herantis Pharma Oyj: Manager's Transactions - Pekka Simula Herantis Pharma Plc Company release 21 December 2018 at 9:00 am Herantis…

Read More

Herantis Pharma Plc's financial reporting schedule and annual general meeting in 2019

Herantis Pharma Plc's financial reporting schedule and annual general meeting in 2019 Herantis Pharma Plc. Company release 18 December 2018…

Read More

Herantis Pharma Oyj: Manager's Transactions - Pekka Simula

Herantis Pharma Oyj: Manager's Transactions - Pekka Simula Herantis Pharma Plc Company release 22 October 2018 at 9:00 am Herantis…

Read More

Investors

Herantis shares are listed on NASDAQ OMX Helsinki First North Finland. Read More

New therapies for a better life.